Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case report
STRI (Stem Cell Treatment & Research Institute), US Patent Registration of the Nerve Cell Differentiation Technology of nEPS (newly Elicited Pluripotent Stem Cell without Side Effects by natural compounds)
[한국경제] 2019.03.28
STRI (Stem Cell Treatment & Research Institute), US Patent Registration of the Nerve Cell Differentiation Technology of nEPS (newly Elicited Pluripotent Stem Cell without Side Effects by natural compounds)
View Detail: https://www.hankyung.com/society/article/201903286415a
Related posts
